This nationwide retrospective study provides a comprehensive overview of first-line treatment strategies for primary mediastinal B-cell lymphoma (PMBCL) across Italy, reflecting real-world clinical practice.
The analysis underscores significant heterogeneity in treatment regimens, reflecting the absence of a universally accepted standard approach.
Clinical outcomes and treatment tolerability data offer insight into optimizing management strategies and guiding selection of first-line therapies in routine care.
